Skip to content
  • Home
  • Book Bag: 0 items (Full)
    • English
    • 日本語
    • 中文(简体)
    • 中文(繁體)
    • اللغة العربية
  • About
Advanced
  • WCN25-1572 DESIGN AND BASELINE...
  • Cite this
  • Text this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Add to Book Bag Remove from Book Bag
  • Permanent link

WCN25-1572 DESIGN AND BASELINE CHARACTERISTICS OF THE GLOBAL KIDNEY PATIENT TRIALS NETWORK

Bibliographic Details
Published in:Kidney International Reports
Main Authors: Sradha Kotwal, Vlado Perkovic, Meg Jardine, Priya Vart, David Wheeler, Ian de Boer, Hong Zhang, Fan Fan Hou, Yuka Sugawara, Luca De Nicola, Jose Gorriz, Hiddo Heerspink
Format: Article
Language:English
Published: Elsevier 2025-02-01
Online Access:http://www.sciencedirect.com/science/article/pii/S2468024924025579
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://www.sciencedirect.com/science/article/pii/S2468024924025579

Similar Items

  • WCN25-1567 Glomerular disease registry and Biobank (GRIT)– design and baseline results
    by: Sradha Kotwal, et al.
    Published: (2025-02-01)
  • Effects of Semaglutide on CKD in Patients With Type 2 Diabetes
    by: Sradha S. Kotwal, et al.
    Published: (2025-02-01)
  • Barriers to Care: New Medications and CKD
    by: Dana Kim, et al.
    Published: (2024-03-01)
  • WCN24-1868 ASSIST: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CROSSOVER TRIAL OF ATRASENTAN IN PATIENTS WITH IGA NEPHROPATHY (IGAN) ON SGLT2I
    by: Irene L. Noronha, et al.
    Published: (2024-04-01)
  • WCN24-2099 BASELINE CHARACTERISTICS OF THE ALIGN TRIAL: A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL OF ATRASENTAN IN PATIENTS WITH IGAN
    by: Hiddo J.L. Heerspink, et al.
    Published: (2024-04-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs